Trademark: 90858178
Word
ACCUPANEL
Status Date
Friday, May 31, 2024
Filing Date
Friday, July 30, 2021
Published for Opposition
Tuesday, June 14, 2022
9 Laboratory devices for detecting genetic sequences; diagnostic kit for medical experiments comprising microcentrifuge tubes for medical research use
5 medical diagnostic test kits comprising medical diagnostic reagents and assays for testing of body fluids, excluding medical diagnostic reagents and assays for use in blood glucose testing and diabetes care
1 diagnostic kit for medical experiments comprising reagents for medical research use
44 Medical testing for diagnostic or treatment purposes in the field of cancer
10 Medical diagnostic apparatus for testing DNA; Medical diagnostic apparatus for testing RNA; Medical diagnostic apparatus for testing cancer cells; Medical diagnostic apparatus for detecting cancer; Genetic testing apparatus for medical purposes; medical diagnostic test kit comprising tubes sold empty for collecting bodily fluids for genetic testing and detecting cancer; blood testing apparatus, excluding blood testing apparatus for use in blood glucose monitoring and diabetes care
42 Development and test of chemical production methods; biotechnology research; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics and pharmacogenetics; Biological research and analysis; biochemical research; Research and development of new products; Pharmaceutical drug development services; Pharmaceutical research services; pharmaceutical products evaluation; Providing laboratory research and medical laboratory services in the field of gene expression; Conducting clinical trials for others; chemical analysis; chemical research
ACCU PANEL; ACCURATE PANEL
Aug 3, 2021
New Application Entered
Sep 27, 2021
New Application Office Supplied Data Entered
Apr 27, 2022
Assigned To Examiner
May 2, 2022
Teas Response To Office Action Received
May 2, 2022
Examiners Amendment And/Or Priority Action - Completed
May 2, 2022
Combined Examiner's Amendment/Priority Action Automatic Entry
May 2, 2022
Examiner's Amendment/Priority Action E-Mailed
May 2, 2022
Notification Of Examiner's Amendment/Priority Action E-Mailed
May 5, 2022
Assigned To Lie
May 6, 2022
Correspondence Received In Law Office
May 6, 2022
Teas/Email Correspondence Entered
May 9, 2022
Approved For Pub - Principal Register
May 9, 2022
Law Office Publication Review Completed
May 25, 2022
Notification Of Notice Of Publication E-Mailed
Jun 14, 2022
Published For Opposition
Jun 14, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 14, 2022
Extension Of Time To Oppose Received
Jul 26, 2022
Teas Post Publication Amendment Received
Aug 9, 2022
Assigned To Petition Staff
Aug 11, 2022
Changes/Corrections After Pub Approval Entered
Oct 23, 2022
Extension Of Time To Oppose Process - Terminated
Dec 6, 2022
Noa E-Mailed - Sou Required From Applicant
Jun 6, 2023
Sou Teas Extension Received
Jun 6, 2023
Sou Extension 1 Filed
Jun 6, 2023
Sou Extension 1 Granted
Jun 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 24, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 24, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 24, 2023
Teas Change Of Correspondence Received
Dec 6, 2023
Sou Teas Extension Received
Dec 6, 2023
Sou Extension 2 Filed
Dec 6, 2023
Sou Extension 2 Granted
Dec 8, 2023
Notice Of Approval Of Extension Request E-Mailed
May 31, 2024
Sou Teas Extension Received
May 31, 2024
Sou Extension 3 Filed
May 31, 2024
Sou Extension 3 Granted
Jun 13, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
